Cambridge biotech files for IPO as it awaits FDA decision on sleep apnea pill

Cambridge biotech Apnimed has filed for an initial public offering as it awaits Food and Drug Administration approval for its ...

Billionaire’s family office plans expansion

This week's banking and finance news in South Florida.